Biostatistics Advance Access originally published online on February 24, 2006
Biostatistics 2006 7(3):486-502; doi:10.1093/biostatistics/kxj021
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Efficient semiparametric estimation of haplotype-disease associations in case–cohort and nested case–control studies
Department of Biostatistics, CB# 7420, University of North Carolina, Chapel Hill, NC 27599-7420, USA lin{at}bios.unc.edu
Department of Epidemiology, CB# 7435, University of North Carolina, Chapel Hill, NC 27599-7420, USA
Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
* To whom correspondence should be addressed.
Estimating the effects of haplotypes on the age of onset of a disease is an important step toward the discovery of genes that influence complex human diseases. A haplotype is a specific sequence of nucleotides on the same chromosome of an individual and can only be measured indirectly through the genotype. We consider cohort studies which collect genotype data on a subset of cohort members through case–cohort or nested case–control sampling. We formulate the effects of haplotypes and possibly time-varying environmental variables on the age of onset through a broad class of semiparametric regression models. We construct appropriate nonparametric likelihoods, which involve both finite- and infinite-dimensional parameters. The corresponding nonparametric maximum likelihood estimators are shown to be consistent, asymptotically normal, and asymptotically efficient. Consistent variance–covariance estimators are provided, and efficient and reliable numerical algorithms are developed. Simulation studies demonstrate that the asymptotic approximations are accurate in practical settings and that case–cohort and nested case–control designs are highly cost-effective. An application to a major cardiovascular study is provided.
Keywords: Age of onset; Association studies; Censoring; Haplotype effects; Nonparametric likelihood; Proportional hazards; Semiparametric efficiency; Single nucleotide polymorphisms; Survival data
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. DeMichele, R. Gray, M. Horn, J. Chen, R. Aplenc, W. P. Vaughan, and M. S. Tallman Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer Cancer Res., May 15, 2009; 69(10): 4184 - 4191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Siedlinski, C. C. van Diemen, D. S. Postma, J. M. Vonk, and H. M. Boezen Superoxide dismutases, lung function and bronchial responsiveness in a general population Eur. Respir. J., May 1, 2009; 33(5): 986 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Galanter, S. Choudhry, C. Eng, S. Nazario, J. R. Rodriguez-Santana, J. Casal, A. Torres-Palacios, J. Salas, R. Chapela, H. G. Watson, et al. ORMDL3 Gene Is Associated with Asthma in Three Ethnically Diverse Populations Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1194 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Cai, N. Kataoka, C. Li, W. Wen, J. R. Smith, Y.-T. Gao, X. O. Shu, and W. Zheng Haplotype Analyses of CYP19A1 Gene Variants and Breast Cancer Risk: Results from the Shanghai Breast Cancer Study Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 27 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hughes, O. Agbaje, R. L. Bowen, D. L. Holliday, J. A. Shaw, S. Duffy, and J. L. Jones Matrix Metalloproteinase Single-Nucleotide Polymorphisms and Haplotypes Predict Breast Cancer Progression Clin. Cancer Res., November 15, 2007; 13(22): 6673 - 6680. [Abstract] [Full Text] [PDF]
|
|